References
Key articles
Wolfe F, Clauw DJ, Fitzcharles MA, et al. 2016 revisions to the 2010/2011 fibromyalgia diagnostic criteria. Semin Arthritis Rheum. 2016 Dec;46(3):319-29. Abstract
Fitzcharles MA, Ste-Marie PA, Goldenberg DL, et al; Canadian Fibromyalgia Guidelines Committee. 2012 Canadian guidelines for the diagnosis and management of fibromyalgia syndrome. Aug 2012 [internet publication].Full text
Macfarlane GJ, Kronisch C, Dean LE, et al. EULAR revised recommendations for the management of fibromyalgia. Ann Rheum Dis. 2017 Feb;76(2):318-28.Full text Abstract
Goldenberg DL, Burckhardt C, Crofford L. Management of fibromyalgia syndrome. JAMA. 2004 Nov 17;292(19):2388-95.Full text Abstract
Reference articles
1. Wolfe F, Walitt B, Rasker JJ, et al. Primary and secondary fibromyalgia are the same: the universality of polysymptomatic distress. J Rheumatol. 2019 Feb;46(2):204-12.Full text Abstract
2. Castro-Sánchez AM, Matarán-Peñarrocha GA, López-Rodríguez MM, et al. Gender differences in pain severity, disability, depression, and widespread pressure pain sensitivity in patients with fibromyalgia syndrome without comorbid conditions. Pain Med. 2012 Dec;13(12):1639-47.Full text Abstract
3. Miró E, Diener FN, Martínez MP, et al. Fibromyalgia in men and women: comparison of the main clinical symptoms. Psicothema. 2012 Feb;24(1):10-5. Abstract
4. Wolfe F, Walitt B, Perrot S, et al. Fibromyalgia diagnosis and biased assessment: sex, prevalence and bias. PLoS One. 2018;13(9):e0203755.Full text Abstract
5. Conversano C, Ciacchini R, Orrù G, et al. Gender differences on psychological factors in fibromyalgia: a systematic review on the male experience. Clin Exp Rheumatol. 2021 May-Jun;39 Suppl 130(3):174-85.Full text Abstract
6. Yunus MB. Gender differences in fibromyalgia and other related syndromes. J Gend Specif Med. 2002 Mar-Apr;5(2):42-7. Abstract
7. Vincent A, Lahr BD, Wolfe F, et al. Prevalence of fibromyalgia: a population-based study in Olmsted County, Minnesota, utilizing the Rochester Epidemiology Project. Arthritis Care Res (Hoboken). 2013 May;65(5):786-92. Abstract
8. Jones GT, Atzeni F, Beasley M, et al. The prevalence of fibromyalgia in the general population: a comparison of the American College of Rheumatology 1990, 2010, and modified 2010 classification criteria. Arthritis Rheumatol. 2015 Feb;67(2):568-75.Full text Abstract
9. Wolfe F. The epidemiology of fibromyalgia. J Musculoskel Pain. 1993;1:137.
10. Wolfe F, Clauw DJ, Fitzcharles MA, et al. Fibromyalgia criteria and severity scales for clinical and epidemiological studies: a modification of the ACR Preliminary Diagnostic Criteria for Fibromyalgia. J Rheumatol. 2011 Jun;38(6):1113-22.Full text Abstract
11. Marques AP, Espírito Santo AS, Berssaneti AA, et al. Prevalence of fibromyalgia: literature review update. Rev Bras Reumatol Engl Ed. 2017 Jul-Aug;57(4):356-63.Full text Abstract
12. Arnold LM, Hudson JI, Hess EV, et al. Family study of fibromyalgia. Arthritis Rheum. 2004 Mar;50(3):944-52.Full text Abstract
13. Hudson JI, Hudson MS, Pliner LF, et al. Fibromyalgia and major affective disorder: a controlled phenomenology and family history study. Am J Psychiatry. 1985 Apr;142(4):441-6. Abstract
14. Mogil JS, Yu L, Basbaum AI. Pain genes?: natural variation and transgenic mutants. Annu Rev Neurosci. 2000 Mar;23:777-811. Abstract
15. Diatchenko L, Nackley AG, Tchivileva IE, et al. Genetic architecture of human pain perception. Trends Genet. 2007 Dec;23(12):605-13. Abstract
16. Tegeder I, Costigan M, Griffin RS, et al. GTP cyclohydrolase and tetrahydrobiopterin regulate pain sensitivity and persistence. Nat Med. 2006 Nov;12(11):1269-77. Abstract
17. Kleykamp BA, Ferguson MC, McNicol E, et al. The prevalence of psychiatric and chronic pain comorbidities in fibromyalgia: an ACTTION systematic review. Semin Arthritis Rheum. 2021 Feb;51(1):166-74.Full text Abstract
18. Kato K, Sullivan PF, Evengard B, et al. Chronic widespread pain and its comorbidities: a population-based study. Arch Intern Med. 2006 Aug 14-28;166(15):1649-54. Abstract
19. Kato K, Sullivan PF, Evengard B, et al. A population-based twin study of functional somatic syndromes. Psychol Med. 2009 Mar;39(3):497-505. Abstract
20. Markkula R, Järvinen P, Leino-Arjas P, et al. Clustering of symptoms associated with fibromyalgia in a Finnish twin cohort. Eur J Pain. 2009 Aug;13(7):744-50. Abstract
21. Balagué F, Nordin M. Back pain in children and teenagers. Baillieres Clin Rheumatol. 1992 Oct;6(3):575-93. Abstract
22. Drossman DA, Li Z, Andruzzi E, et al. U.S. householder survey of functional gastrointestinal disorders. Prevalence, sociodemography, and health impact. Dig Dis Sci. 1993 Sep;38(9):1569-80. Abstract
23. Aaron LA, Bradley LA, Alarcón GS, et al. Psychiatric diagnoses in patients with fibromyalgia are related to health care-seeking behavior rather than to illness. Arthritis Rheum. 1996 Mar;39(3):436-45. Abstract
24. Staud R. Abnormal pain modulation in patients with spatially distributed chronic pain: fibromyalgia. Rheum Dis Clin North Am. 2009 May;35(2):263-74.Full text Abstract
25. O'Brien AT, Deitos A, Triñanes Pego Y, et al. Defective endogenous pain modulation in fibromyalgia: a meta-analysis of temporal summation and conditioned pain modulation paradigms. J Pain. 2018 Aug;19(8):819-36.Full text Abstract
26. Jensen KB, Kosek E, Petzke F, et al. Evidence of dysfunctional pain inhibition in fibromyalgia reflected in rACC during provoked pain. Pain. 2009 Jul;144(1-2):95-100. Abstract
27. Julien N, Goffaux P, Arsenault P, et al. Widespread pain in fibromyalgia is related to a deficit of endogenous pain inhibition. Pain. 2005 Mar;114(1-2):295-302. Abstract
28. Montoya P, Sitges C, García-Herrera M, et al. Reduced brain habituation to somatosensory stimulation in patients with fibromyalgia. Arthritis Rheum. 2006 Jun;54(6):1995-2003.Full text Abstract
29. Russell IJ, Orr MD, Littman B, et al. Elevated cerebrospinal fluid levels of substance P in patients with the fibromyalgia syndrome. Arthritis Rheum. 1994 Nov;37(11):1593-601.Full text Abstract
30. Haas L, Portela LV, Böhmer AE, et al. Increased plasma levels of brain derived neurotrophic factor (BDNF) in patients with fibromyalgia. Neurochem Res. 2010 May;35(5):830-4. Abstract
31. Staud R, Godfrey MM, Robinson ME. Fibromyalgia patients are not only hypersensitive to painful stimuli but also to acoustic stimuli. J Pain. 2021 Aug;22(8):914-25.Full text Abstract
32. Hubbard CS, Lazaridou A, Cahalan CM, et al. Aberrant salience? Brain hyperactivation in response to pain onset and offset in fibromyalgia. Arthritis Rheumatol. 2020 Jul;72(7):1203-13. Abstract
33. Giesecke T, Gracely RH, Williams DA, et al. The relationship between depression, clinical pain, and experimental pain in a chronic pain cohort. Arthritis Rheum. 2005 May;52(5):1577-84.Full text Abstract
34. Kim J, Loggia ML, Cahalan CM, et al. The somatosensory link in fibromyalgia: functional connectivity of the primary somatosensory cortex is altered by sustained pain and is associated with clinical/autonomic dysfunction. Arthritis Rheumatol. 2015 May;67(5):1395-405.Full text Abstract
35. Loggia ML, Berna C, Kim J, et al. Disrupted brain circuitry for pain-related reward/punishment in fibromyalgia. Arthritis Rheumatol. 2014 Jan;66(1):203-12.Full text Abstract
36. Kamping S, Bomba IC, Kanske P, et al. Deficient modulation of pain by a positive emotional context in fibromyalgia patients. Pain. 2013 Sep;154(9):1846-55. Abstract
37. Balducci T, Garza-Villarreal EA, Valencia A, et al. Abnormal functional neurocircuitry underpinning emotional processing in fibromyalgia. Eur Arch Psychiatry Clin Neurosci. 2023 Mar 24.Full text Abstract
38. Roizenblatt S, Neto NS, Tufik S. Sleep disorders and fibromyalgia. Curr Pain Headache Rep. 2011 Oct;15(5):347-57. Abstract
39. Moldofsky H. The significance of dysfunctions of the sleeping/waking brain to the pathogenesis and treatment of fibromyalgia syndrome. Rheum Dis Clin North Am. 2009 May;35(2):275-83. Abstract
40. Fang SC, Wu YL, Chen SC, et al. Subjective sleep quality as a mediator in the relationship between pain severity and sustained attention performance in patients with fibromyalgia. J Sleep Res. 2019 Dec;28(6):e12843. Abstract
41. Celepkolu T, Gamze Erten Bucaktepe P, Yilmaz A, et al. Assessment of quality of life, anxiety, depression, and sleep quality in women with fibromyalgia and their spouses. Eur Rev Med Pharmacol Sci. 2021 Jul;25(13):4506-13.Full text Abstract
42. Roehrs T, Diederichs C, Gillis M, et al. Nocturnal sleep, daytime sleepiness and fatigue in fibromyalgia patients compared to rheumatoid arthritis patients and healthy controls: a preliminary study. Sleep Med. 2013 Jan;14(1):109-15.Full text Abstract
43. Yeung WK, Morgan K, Mckenna F. Comparison of sleep structure and psychometric profiles in patients with fibromyalgia, osteoarthritis and healthy controls. J Sleep Res. 2018 Apr;27(2):290-8. Abstract
44. Mork PJ, Nilsen TI. Sleep problems and risk of fibromyalgia: longitudinal data on an adult female population in Norway. Arthritis Rheum. 2012 Jan;64(1):281-4.Full text Abstract
45. Pednekar DD, Amin MR, Azgomi HF, et al. A system theoretic investigation of cortisol dysregulation in fibromyalgia patients with chronic fatigue. Annu Int Conf IEEE Eng Med Biol Soc. 2019 Jul;2019:6896-901. Abstract
46. Pednekar DD, Amin MR, Azgomi HF, et al. Characterization of cortisol dysregulation in fibromyalgia and chronic fatigue syndromes: a state-space approach. IEEE Trans Biomed Eng. 2020 Nov;67(11):3163-72.Full text Abstract
47. Úbeda-D'Ocasar E, Jiménez Díaz-Benito V, Gallego-Sendarrubias GM, et al. Pain and cortisol in patients with fibromyalgia: systematic review and meta-analysis. Diagnostics (Basel). 2020 Nov 9;10(11):922.Full text Abstract
48. Adler GK, Kinsley BT, Hurwitz S, et al. Reduced hypothalamic-pituitary and sympathoadrenal responses to hypoglycemia in women with fibromyalgia syndrome. Am J Med. 1999 May;106(5):534-43. Abstract
49. McLean SA, Williams DA, Harris RE, et al. Momentary relationship between cortisol secretion and symptoms in patients with fibromyalgia. Arthritis Rheum. 2005 Nov;52(11):3660-9.Full text Abstract
50. McBeth J, Silman AJ, Gupta A, et al. Moderation of psychosocial risk factors through dysfunction of the hypothalamic-pituitary-adrenal stress axis in the onset of chronic widespread musculoskeletal pain: findings of a population-based prospective cohort study. Arthritis Rheum. 2007 Jan;56(1):360-71.Full text Abstract
51. Riva R, Mork PJ, Westgaard RH, et al. Catecholamines and heart rate in female fibromyalgia patients. J Psychosom Res. 2012 Jan;72(1):51-7.Full text Abstract
52. Kadetoff D, Kosek E. Evidence of reduced sympatho-adrenal and hypothalamic-pituitary activity during static muscular work in patients with fibromyalgia. J Rehabil Med. 2010 Sep;42(8):765-72.Full text Abstract
53. Parati G, Mancia G, Di Rienzo M, et al. Point: cardiovascular variability is/is not an index of autonomic control of circulation. J Appl Physiol (1985). 2006 Aug;101(2):676-8; discussion 681-2.Full text Abstract
54. Lerma C, Martinez A, Ruiz N, et al. Nocturnal heart rate variability parameters as potential fibromyalgia biomarker: correlation with symptoms severity. Arthritis Res Ther. 2011;13(6):R185.Full text Abstract
55. Vreijling SR, Troudart Y, Brosschot JF. Reduced heart rate variability in patients with medically Uunexplained physical symptoms: a meta-analysis of HF-HRV and RMSSD. Psychosom Med. 2021 Jan;83(1):2-15. Abstract
56. Caro XJ, Winter EF, Dumas AJ. A subset of fibromyalgia patients have findings suggestive of chronic inflammatory demyelinating polyneuropathy and appear to respond to IVIg. Rheumatology (Oxford). 2008 Feb;47(2):208-11.Full text Abstract
57. Kim SH, Kim DH, Oh DH, et al. Characteristic electron microscopic findings in the skin of patients with fibromyalgia - preliminary study. Clin Rheumatol. 2008 Mar;27(3):407-11. Abstract
58. Oaklander AL, Fields HL. Is reflex sympathetic dystrophy/complex regional pain syndrome type I a small-fiber neuropathy? Ann Neurol. 2009 Jun;65(6):629-38. Abstract
59. Grayston R, Czanner G, Elhadd K, et al. A systematic review and meta-analysis of the prevalence of small fiber pathology in fibromyalgia: implications for a new paradigm in fibromyalgia etiopathogenesis. Semin Arthritis Rheum. 2019 Apr;48(5):933-40.Full text Abstract
60. Apkarian AV, Sosa Y, Sonty S, et al. Chronic back pain is associated with decreased prefrontal and thalamic gray matter density. J Neurosci. 2004 Nov 17;24(46):10410-5.Full text Abstract
61. Sundgren PC, Petrou M, Harris RE, et al. Diffusion-weighted and diffusion tensor imaging in fibromyalgia patients: a prospective study of whole brain diffusivity, apparent diffusion coefficient, and fraction anisotropy in different regions of the brain and correlation with symptom severity. Acad Radiol. 2007 Jul;14(7):839-46. Abstract
62. Kuchinad A, Schweinhardt P, Seminowicz DA, et al. Accelerated brain gray matter loss in fibromyalgia patients: premature aging of the brain? J Neurosci. 2007 Apr 11;27(15):4004-7.Full text Abstract
63. Luerding R, Weigand T, Bogdahn U, et al. Working memory performance is correlated with local brain morphology in the medial frontal and anterior cingulate cortex in fibromyalgia patients: structural correlates of pain-cognition interaction. Brain. 2008 Dec;131(Pt 12):3222-31.Full text Abstract
64. Lutz J, Jäger L, de Quervain D, et al. White and gray matter abnormalities in the brain of patients with fibromyalgia: a diffusion-tensor and volumetric imaging study. Arthritis Rheum. 2008 Dec;58(12):3960-9.Full text Abstract
65. Schmidt-Wilcke T. Variations in brain volume and regional morphology associated with chronic pain. Curr Rheumatol Rep. 2008 Dec;10(6):467-74. Abstract
66. Hsu MC, Harris RE, Sundgren PC, et al. No consistent difference in gray matter volume between individuals with fibromyalgia and age-matched healthy subjects when controlling for affective disorder. Pain. 2009 Jun;143(3):262-7. Abstract
67. Coskun Benlidayi I. Role of inflammation in the pathogenesis and treatment of fibromyalgia. Rheumatol Int. 2019 May;39(5):781-91.Full text Abstract
68. Banfi G, Diani M, Pigatto PD, et al. T cell subpopulations in the physiopathology of fibromyalgia: evidence and perspectives. Int J Mol Sci. 2020 Feb 11;21(4):1186.Full text Abstract
69. Sluka KA, Clauw DJ. Neurobiology of fibromyalgia and chronic widespread pain. Neuroscience. 2016 Dec 3;338:114-29.Full text Abstract
70. Stormorken H, Brosstad F. Fibromyalgia: family clustering and sensory urgency with early onset indicate genetic predisposition and thus a "true" disease. Scand J Rheumatol. 1992;21(4):207. Abstract
71. Pellegrino MJ, Waylonis GW, Sommer A. Familial occurrence of primary fibromyalgia. Arch Phys Med Rehabil. 1989 Jan;70(1):61-3. Abstract
72. Buskila D, Sarzi-Puttini P, Ablin JN. The genetics of fibromyalgia syndrome. Pharmacogenomics. 2007 Jan;8(1):67-74. Abstract
73. Buskila D, Sarzi-Puttini P. Biology and therapy of fibromyalgia: genetic aspects of fibromyalgia syndrome. Arthritis Res Ther. 2006 Jul 28;8(5):218.Full text Abstract
74. Limer KL, Nicholl BI, Thomson W, et al. Exploring the genetic susceptibility of chronic widespread pain: the tender points in genetic association studies. Rheumatology (Oxford). 2008 May;47(5):572-7.Full text Abstract
75. Martínez-Jauand M, Sitges C, Rodríguez V, et al. Pain sensitivity in fibromyalgia is associated with catechol-O-methyltransferase (COMT) gene. Eur J Pain. 2013 Jan;17(1):16-27. Abstract
76. Nicholl BI, Holliday KL, Macfarlane GJ, et al. Association of HTR2A polymorphisms with chronic widespread pain and the extent of musculoskeletal pain: results from two population-based cohorts. Arthritis Rheum. 2011 Mar;63(3):810-8.Full text Abstract
77. Estévez-López F, Guerrero-González JM, Salazar-Tortosa D, et al. Interplay between genetics and lifestyle on pain susceptibility in women with fibromyalgia: the al-Ándalus project. Rheumatology (Oxford). 2022 Aug 3;61(8):3180-91.Full text Abstract
78. Zhao SS, Duffield SJ, Goodson NJ. The prevalence and impact of comorbid fibromyalgia in inflammatory arthritis. Best Pract Res Clin Rheumatol. 2019 Jun;33(3):101423.Full text Abstract
79. Phillips K, Clauw DJ. Central pain mechanisms in chronic pain states - maybe it is all in their head. Best Pract Res Clin Rheumatol. 2011 Apr;25(2):141-54. Abstract
80. White KP, Harth M. Classification, epidemiology, and natural history of fibromyalgia. Curr Pain Headache Rep. 2001 Aug;5(4):320-9. Abstract
81. Kaleycheva N, Cullen AE, Evans R, et al. The role of lifetime stressors in adult fibromyalgia: systematic review and meta-analysis of case-control studies. Psychol Med. 2021 Jan;51(2):177-93.Full text Abstract
82. Oliveira ÍMX, Silva RDSUD. Rheumatological manifestations associated with viral hepatitis B or C. Rev Soc Bras Med Trop. 2019;52:e20180407.Full text Abstract
83. Ablin JN, Shoenfeld Y, Buskila D. Fibromyalgia, infection and vaccination: two more parts in the etiological puzzle. J Autoimmun. 2006 Nov;27(3):145-52.Full text Abstract
84. Cassisi G, Sarzi-Puttini P, Cazzola M. Chronic widespread pain and fibromyalgia: could there be some relationships with infections and vaccinations? Clin Exp Rheumatol. 2011 Nov-Dec;29(6 suppl 69):S118-26. Abstract
85. Ursini F, Ciaffi J, Mancarella L, et al. Fibromyalgia: a new facet of the post-COVID-19 syndrome spectrum? Results from a web-based survey. RMD Open. 2021 Aug;7(3):e001735.Full text Abstract
86. Savin E, Rosenn G, Tsur AM, et al. The possible onset of fibromyalgia following acute COVID-19 infection. PLoS One. 2023;18(2):e0281593.Full text Abstract
87. Huisman AM, White KP, Algra A, et al. Vitamin D levels in women with systemic lupus erythematosus and fibromyalgia. J Rheumatol. 2001 Nov;28(11):2535-9.Full text Abstract
88. McCabe PS, Pye SR, Beth JM, et al. Low vitamin D and the risk of developing chronic widespread pain: results from the European male ageing study. BMC Musculoskelet Disord. 2016 Jan 16;17:32.Full text Abstract
89. Bhatty SA, Shaikh NA, Irfan M, et al. Vitamin D deficiency in fibromyalgia. J Pak Med Assoc. 2010 Nov;60(11):949-51. Abstract
90. Plotnikoff GA, Quigley JM. Prevalence of severe hypovitaminosis D in patients with persistent, nonspecific musculoskeletal pain. Mayo Clin Proc. 2003 Dec;78(12):1463-70. Abstract
91. Martins YA, Cardinali CAEF, Ravanelli MI, et al. Is hypovitaminosis D associated with fibromyalgia? A systematic review. Nutr Rev. 2020 Feb;78(2):115-33.Full text Abstract
92. Goldenberg DL. Diagnosing fibromyalgia as a disease, an illness, a state, or a trait? Arthritis Care Res (Hoboken). 2019 Mar;71(3):334-6.Full text Abstract
93. Arnold LM, Bennett RM, Crofford LJ, et al. AAPT diagnostic criteria for fibromyalgia. J Pain. 2019 Jun;20(6):611-28.Full text Abstract
94. Wolfe F, Clauw DJ, Fitzcharles MA, et al. 2016 revisions to the 2010/2011 fibromyalgia diagnostic criteria. Semin Arthritis Rheum. 2016 Dec;46(3):319-29. Abstract
95. Wu YL, Chang LY, Lee HC, et al. Sleep disturbances in fibromyalgia: a meta-analysis of case-control studies. J Psychosom Res. 2017 May;96:89-97.Full text Abstract
96. Marvisi M, Balzarini L, Mancini C, et al. Fibromyalgia is frequent in obstructive sleep apnea and responds to CPAP therapy. Eur J Intern Med. 2015 Nov;26(9):e49-50. Abstract
97. Terzi R, Yılmaz Z. Evaluation of pain sensitivity by tender point counts and myalgic score in patients with and without obstructive sleep apnea syndrome. Int J Rheum Dis. 2017 Mar;20(3):340-5.Full text Abstract
98. Mutlu P, Zateri C, Zohra A, et al. Prevalence of obstructive sleep apnea in female patients with fibromyalgia. Saudi Med J. 2020 Jul;41(7):740-5.Full text Abstract
99. Altıntop Geçkil A, Aydoğan Baykara R. Coexistence of obstructive sleep apnea syndrome and fibromyalgia. Tuberk Toraks. 2022 Mar;70(1):37-43. Abstract
100. Torta RG, Tesio V, Ieraci V, et al. Fibro-fog. Clin Exp Rheumatol. 2016 Mar-Apr;34(2 suppl 96):S6-8. Abstract
101. Bell T, Trost Z, Buelow MT, et al. Meta-analysis of cognitive performance in fibromyalgia. J Clin Exp Neuropsychol. 2018 Sep;40(7):698-714.Full text Abstract
102. Wu YL, Huang CJ, Fang SC, et al. Cognitive impairment in fibromyalgia: a meta-analysis of case-control studies. Psychosom Med. 2018 Jun;80(5):432-8. Abstract
103. Dadabhoy D, Crofford LJ, Spaeth M, et al. Biology and therapy of fibromyalgia: evidence-based biomarkers for fibromyalgia syndrome. Arthritis Res Ther. 2008 Aug 8;10(4):211.Full text Abstract
104. Berwick RJ, Siew S, Andersson DA, et al. A systematic review into the influence of temperature on fibromyalgia pain: meteorological studies and quantitative sensory testing. J Pain. 2021 May;22(5):473-86.Full text Abstract
105. Ten Brink AF, Bultitude JH. Visual sensitivity in complex regional pain syndrome and fibromyalgia: an online study. Perception. 2022 Mar;51(3):187-209.Full text Abstract
106. Ayouni I, Chebbi R, Hela Z, et al. Comorbidity between fibromyalgia and temporomandibular disorders: a systematic review. Oral Surg Oral Med Oral Pathol Oral Radiol. 2019 Jul;128(1):33-42. Abstract
107. Besiroglu MDH, Dursun MDM. The association between fibromyalgia and female sexual dysfunction: a systematic review and meta-analysis of observational studies. Int J Impot Res. 2019 Jul;31(4):288-97. Abstract
108. Ricoy-Cano AJ, Cortés-Pérez I, Del Carmen Martín-Cano M, et al. Impact of fibromyalgia syndrome on female sexual function: a systematic review with meta-analysis. J Clin Rheumatol. 2022 Mar 1;28(2):e574-82. Abstract
109. Thornton KGS, Robert M. Prevalence of pelvic floor disorders in the fibromyalgia population: a systematic review. J Obstet Gynaecol Can. 2020 Jan;42(1):72-9. Abstract
111. Jensen TS, Finnerup NB. Allodynia and hyperalgesia in neuropathic pain: clinical manifestations and mechanisms. Lancet Neurol. 2014 Sep;13(9):924-35. Abstract
112. Wolfe F, Smythe HA, Yunus MB, et al. The American College of Rheumatology 1990 criteria for the classification of fibromyalgia. Report of the Multicenter Criteria Committee. Arthritis Rheum. 1990 Feb;33(2):160-72.Full text Abstract
113. Arora N, Gupta A, Reddy SB. Antinuclear antibody and subserology testing in the evaluation of fibromyalgia: a teachable moment. JAMA Intern Med. 2017 Sep;177(9):1369-70. Abstract
114. Bossema ER, van Middendorp H, Jacobs JW, et al. Influence of weather on daily symptoms of pain and fatigue in female patients with fibromyalgia: a multilevel regression analysis. Arthritis Care Res (Hoboken). 2013 Jul;65(7):1019-25.Full text Abstract
115. de Tommaso M, Federici A, Serpino C, et al. Clinical features of headache patients with fibromyalgia comorbidity. J Headache Pain. 2011 Dec;12(6):629-38.Full text Abstract
116. Giesecke T, Williams DA, Harris RE, et al. Subgrouping of fibromyalgia patients on the basis of pressure-pain thresholds and psychological factors. Arthritis Rheum. 2003 Oct;48(10):2916-22.Full text Abstract
117. Komaroff AL. Myalgic encephalomyelitis/chronic fatigue syndrome: a real illness. Ann Intern Med. 2015 Jun;162(12):871-2.Full text Abstract
118. Wolfe F, Clauw DJ, Fitzcharles MA, et al. The American College of Rheumatology preliminary diagnostic criteria for fibromyalgia and measurement of symptom severity. Arthritis Care Res (Hoboken). 2010 May;62(5):600-10.Full text Abstract
119. Fitzcharles MA, Ste-Marie PA, Goldenberg DL, et al; Canadian Fibromyalgia Guidelines Committee. 2012 Canadian guidelines for the diagnosis and management of fibromyalgia syndrome. Aug 2012 [internet publication].Full text
120. Macfarlane GJ, Kronisch C, Dean LE, et al. EULAR revised recommendations for the management of fibromyalgia. Ann Rheum Dis. 2017 Feb;76(2):318-28.Full text Abstract
121. Migliorini F, Maffulli N, Eschweiler J, et al. BMI but not age and sex negatively impact on the outcome of pharmacotherapy in fibromyalgia: a systematic review. Expert Rev Clin Pharmacol. 2021 Aug;14(8):1029-1038.Full text Abstract
122. Bennett RM, Friend R, Jones KD, et al. The revised fibromyalgia impact questionnaire (FIQR): validation and psychometric properties. Arthritis Res Ther. 2009;11(4):R120.Full text Abstract
123. Salaffi F, Di Carlo M, Arcà S, et al. Categorisation of disease severity states in fibromyalgia: a first step to support decision-making in health care policy. Clin Exp Rheumatol. 2018 Nov-Dec;36(6):1074-1081.Full text Abstract
124. Hernando-Garijo I, Jiménez-Del-Barrio S, Mingo-Gómez T, et al. Effectiveness of non-pharmacological conservative therapies in adults with fibromyalgia: a systematic review of high-quality clinical trials. J Back Musculoskelet Rehabil. 2022;35(1):3-20.Full text Abstract
125. Goldenberg DL, Burckhardt C, Crofford L. Management of fibromyalgia syndrome. JAMA. 2004 Nov 17;292(19):2388-95.Full text Abstract
126. Geraghty AWA, Maund E, Newell D, et al. Self-management for chronic widespread pain including fibromyalgia: A systematic review and meta-analysis. PLoS One. 2021;16(7):e0254642.Full text Abstract
127. García-Ríos MC, Navarro-Ledesma S, Tapia-Haro RM, et al. Effectiveness of health education in patients with fibromyalgia: a systematic review. Eur J Phys Rehabil Med. 2019 Apr;55(2):301-313. Abstract
128. Musekamp G, Gerlich C, Ehlebracht-Kï Nig I, et al. Evaluation of a self-management patient education programme for fibromyalgia-results of a cluster-RCT in inpatient rehabilitation. Health Educ Res. 2019 Apr 1;34(2):209-22. Abstract
129. Kim CH, Luedtke CA, Vincent A, et al. Association of body mass index with symptom severity and quality of life in patients with fibromyalgia. Arthritis Care Res (Hoboken). 2012 Feb;64(2):222-8.Full text Abstract
130. Atzeni F, Alciati A, Salaffi F, et al. The association between body mass index and fibromyalgia severity: data from a cross-sectional survey of 2339 patients. Rheumatol Adv Pract. 2021;5(1):rkab015.Full text Abstract
131. D'Onghia M, Ciaffi J, Lisi L, et al. Fibromyalgia and obesity: a comprehensive systematic review and meta-analysis. Semin Arthritis Rheum. 2021 Apr;51(2):409-24.Full text Abstract
132. Busch AJ, Webber SC, Richards RS, et al. Resistance exercise training for fibromyalgia. Cochrane Database Syst Rev. 2013 Dec 20;2013(12):CD010884.Full text Abstract
133. Bidonde J, Busch AJ, Schachter CL, et al. Mixed exercise training for adults with fibromyalgia. Cochrane Database Syst Rev. 2019 May 24;(5):CD013340.Full text Abstract
134. Wang C, Schmid CH, Rones R, et al. A randomized trial of tai chi for fibromyalgia. N Engl J Med. 2010 Aug 19;363(8):743-54.Full text Abstract
135. Barker AL, Talevski J, Morello RT, et al. Effectiveness of aquatic exercise for musculoskeletal conditions: a meta-analysis. Arch Phys Med Rehabil. 2014 Sep;95(9):1776-86. Abstract
136. Estévez-López F, Maestre-Cascales C, Russell D, et al. Effectiveness of exercise on fatigue and sleep quality in fibromyalgia: a systematic review and meta-analysis of randomized trials. Arch Phys Med Rehabil. 2021 Apr;102(4):752-61.Full text Abstract
137. Cheng CA, Chiu YW, Wu D, et al. Effectiveness of Tai Chi on fibromyalgia patients: a meta-analysis of randomized controlled trials. Complement Ther Med. 2019 Oct;46:1-8.Full text Abstract
138. Bravo C, Skjaerven LH, Guitard Sein-Echaluce L, et al. Effectiveness of movement and body awareness therapies in patients with fibromyalgia: a systematic review and meta-analysis. Eur J Phys Rehabil Med. 2019 Oct;55(5):646-57. Abstract
139. Andrade A, de Azevedo Klumb Steffens R, Sieczkowska SM, et al. A systematic review of the effects of strength training in patients with fibromyalgia: clinical outcomes and design considerations. Adv Rheumatol. 2018 Oct 22;58(1):36. Abstract
140. Vilarino GT, Andreato LV, de Souza LC, et al. Effects of resistance training on the mental health of patients with fibromyalgia: a systematic review. Clin Rheumatol. 2021 Nov;40(11):4417-25. Abstract
141. Bidonde J, Busch AJ, Schachter CL, et al. Aerobic exercise training for adults with fibromyalgia. Cochrane Database Syst Rev. 2017 Jun;6(6):CD012700.Full text Abstract
142. Ferro Moura Franco K, Lenoir D, Dos Santos Franco YR, et al. Prescription of exercises for the treatment of chronic pain along the continuum of nociplastic pain: a systematic review with meta-analysis. Eur J Pain. 2021 Jan;25(1):51-70.Full text Abstract
143. Williams ACC, Fisher E, Hearn L, et al. Psychological therapies for the management of chronic pain (excluding headache) in adults. Cochrane Database Syst Rev. 2020 Aug 12;8(8):CD007407.Full text Abstract
144. Samami E, Shahhosseini Z, Elyasi F. The effect of psychological interventions on the quality of life in women with fibromyalgia: a systematic review. J Clin Psychol Med Settings. 2021 Sep;28(3):503-17. Abstract
145. Williams DA, Kuper D, Segar M, et al. Internet-enhanced management of fibromyalgia: a randomized controlled trial. Pain. 2010 Dec;151(3):694-702. Abstract
146. Nüesch E, Häuser W, Bernardy K, et al. Comparative efficacy of pharmacological and non-pharmacological interventions in fibromyalgia syndrome: network meta-analysis. Ann Rheum Dis. 2013 Jun;72(6):955-62. Abstract
147. Goldenberg D, Mayskiy M, Mossey C, et al. A randomized, double-blind crossover trial of fluoxetine and amitriptyline in the treatment of fibromyalgia. Arthritis Rheum. 1996 Nov;39(11):1852-9. Abstract
148. Mease PJ, Farmer MV, Palmer RH, et al. Milnacipran combined with pregabalin in fibromyalgia: a randomized, open-label study evaluating the safety and efficacy of adding milnacipran in patients with incomplete response to pregabalin. Ther Adv Musculoskelet Dis. 2013 Jun;5(3):113-26.Full text Abstract
149. Gilron I, Chaparro LE, Tu D, et al. Combination of pregabalin with duloxetine for fibromyalgia: a randomized controlled trial. Pain. 2016 Jul;157(7):1532-40. Abstract
150. Arnold LM, Keck PE Jr, Welge JA. Antidepressant treatment of fibromyalgia: a meta-analysis and review. Psychosomatics. 2000 Mar-Apr;41(2):104-13. Abstract
151. Tofferi JK, Jackson JL, O'Malley PG. Treatment of fibromyalgia with cyclobenzaprine: a meta-analysis. Arthritis Rheum. 2004 Feb 15;51(1):9-13.Full text Abstract
152. O'Malley PG, Balden E, Tomkins G, et al. Treatment of fibromyalgia with antidepressants. J Gen Intern Med. 2000 Sep;15(9):659-66.Full text Abstract
153. Nishishinya B, Urrútia G, Walitt B, et al. Amitriptyline in the treatment of fibromyalgia: a systematic review of its efficacy. Rheumatology (Oxford). 2008 Dec;47(12):1741-6.Full text Abstract
154. Welsch P, Üçeyler N, Klose P, et al. Serotonin and noradrenaline reuptake inhibitors (SNRIs) for fibromyalgia. Cochrane Database Syst Rev. 2018 Feb 28;(2):CD010292.Full text Abstract
155. Lian YN, Wang Y, Zhang Y, et al. Duloxetine for pain in fibromyalgia in adults: a systematic review and a meta-analysis. Int J Neurosci. 2020 Jan;130(1):71-82.Full text Abstract
156. Gendreau RM, Thorn MD, Gendreau JF, et al. Efficacy of milnacipran in patients with fibromyalgia. J Rheumatol. 2005 Oct;32(10):1975-85. Abstract
157. Mease PJ, Clauw DJ, Gendreau RM, et al. The efficacy and safety of milnacipran for treatment of fibromyalgia. A randomized, double-blind, placebo-controlled trial. J Rheumatol. 2009 Feb;36(2):398-409. Abstract
158. Clauw DJ, Mease P, Palmer RH, et al. Milnacipran for the treatment of fibromyalgia in adults: a 15-week, multicenter, randomized, double-blind, placebo-controlled, multiple-dose clinical trial. Clin Ther. 2008 Nov;30(11):1988-2004. Abstract
159. Kyle JA, Dugan BD, Testerman KK. Milnacipran for treatment of fibromyalgia. Ann Pharmacother. 2010 Sep;44(9):1422-9. Abstract
160. Arnold LM, Gendreau RM, Palmer RH, et al. Efficacy and safety of milnacipran 100 mg/day in patients with fibromyalgia: results of a randomized, double-blind, placebo-controlled trial. Arthritis Rheum. 2010 Sep;62(9):2745-56. Abstract
161. de Farias ÁD, Eberle L, Amador TA, et al. Comparing the efficacy and safety of duloxetine and amitriptyline in the treatment of fibromyalgia: overview of systematic reviews. Adv Rheumatol. 2020 Jul 8;60(1):35. Abstract
162. Mease PJ, Russell IJ, Kajdasz DK, et al. Long-term safety, tolerability, and efficacy of duloxetine in the treatment of fibromyalgia. Semin Arthritis Rheum. 2010 Jun;39(6):454-64. Abstract
163. Branco JC, Zachrisson O, Perrot S, et al. A European multicenter randomized double-blind placebo-controlled monotherapy clinical trial of milnacipran in treatment of fibromyalgia. J Rheumatol. 2010 Apr;37(4):851-9. Abstract
164. Brunton S, Wang F, Edwards SB, et al. Profile of adverse events with duloxetine treatment: a pooled analysis of placebo-controlled studies. Drug Saf. 2010 May 1;33(5):393-407. Abstract
165. Choy EH, Mease PJ, Kajdasz DK, et al. Safety and tolerability of duloxetine in the treatment of patients with fibromyalgia: pooled analysis of data from five clinical trials. Clin Rheumatol. 2009 Sep;28(9):1035-44.Full text Abstract
166. Arnold LM, Choy E, Clauw DJ, et al. An evidence-based review of pregabalin for the treatment of fibromyalgia. Curr Med Res Opin. 2018 Aug;34(8):1397-409. Abstract
167. Arnold LM, Goldenberg DL, Stanford SB, et al. Gabapentin in the treatment of fibromyalgia: a randomized, double-blind, placebo-controlled, multicenter trial. Arthritis Rheum. 2007 Apr;56(4):1336-44.Full text Abstract
168. Crofford LJ, Rowbotham MC, Mease PJ, et al. Pregabalin for the treatment of fibromyalgia syndrome: results of a randomized, double-blind, placebo-controlled trial. Arthritis Rheum. 2005 Apr;52(4):1264-73.Full text Abstract
169. Derry S, Cording M, Wiffen PJ, et al. Pregabalin for pain in fibromyalgia in adults. Cochrane Database Syst Rev. 2016 Sep 29;(9):CD011790.Full text Abstract
170. Häuser W, Bernardy K, Uçeyler N, et al. Treatment of fibromyalgia syndrome with gabapentin and pregabalin: a meta-analysis of randomized controlled trials. Pain. 2009 Sep;145(1-2):69-81. Abstract
171. Clauw DJ. Fibromyalgia: a clinical review. JAMA. 2014 Apr 16;311(15):1547-55. Abstract
172. Derry S, Wiffen PJ, Häuser W, et al. Oral nonsteroidal anti-inflammatory drugs for fibromyalgia in adults. Cochrane Database Syst Rev. 2017 Mar 27;(3):CD012332.Full text Abstract
173. Gaskell H, Moore RA, Derry S, et al. Oxycodone for pain in fibromyalgia in adults. Cochrane Database Syst Rev. 2016 Sep 1;(9):CD012329.Full text Abstract
174. da Rocha AP, Mizzaci CC, Nunes Pinto AC, et al. Tramadol for management of fibromyalgia pain and symptoms: systematic review. Int J Clin Pract. 2020 Mar;74(3):e13455. Abstract
175. Mhalla A, Baudic S, Ciampi de Andrade D, et al. Long-term maintenance of the analgesic effects of transcranial magnetic stimulation in fibromyalgia. Pain. 2011 Jul;152(7):1478-85. Abstract
176. O'Connell NE, Marston L, Spencer S, et al. Non-invasive brain stimulation techniques for chronic pain. Cochrane Database Syst Rev. 2018 Apr 13;(4):CD008208.Full text Abstract
177. Fagerlund AJ, Hansen OA, Aslaksen PM. Transcranial direct current stimulation as a treatment for patients with fibromyalgia: a randomized controlled trial. Pain. 2015 Jan;156(1):62-71. Abstract
178. Fregni F, El-Hagrassy MM, Pacheco-Barrios K, et al. Evidence-based guidelines and secondary meta-analysis for the use of transcranial direct current stimulation in neurological and psychiatric disorders. Int J Neuropsychopharmacol. 2021 Apr;24(4):256-313.Full text Abstract
179. Lefaucheur JP, Aleman A, Baeken C, et al. Evidence-based guidelines on the therapeutic use of repetitive transcranial magnetic stimulation (rTMS): an update (2014-2018). Clin Neurophysiol. 2020 Feb;131(2):474-528.Full text Abstract
180. Lloyd DM, Wittkopf PG, Arendsen LJ, et al. Is transcranial direct current stimulation (tDCS) effective for the treatment of pain in fibromyalgia? A systematic review and meta-analysis. J Pain. 2020 Nov-Dec;21(11-12):1085-100.Full text Abstract
181. Hatfield E, Phillips K, Swidan S, et al. Use of low-dose naltrexone in the management of chronic pain conditions: a systematic review. J Am Dent Assoc. 2020 Dec;151(12):891-902.e1. Abstract
182. Younger J, Noor N, McCue R, et al. Low-dose naltrexone for the treatment of fibromyalgia: findings of a small, randomized, double-blind, placebo-controlled, counterbalanced, crossover trial assessing daily pain levels. Arthritis Rheum. 2013 Feb;65(2):529-38.Full text Abstract
183. Lynch ME, Campbell F. Cannabinoids for treatment of chronic non-cancer pain; a systematic review of randomized trials. Br J Clin Pharmacol. 2011 Nov;72(5):735-44.Full text Abstract
184. Walitt B, Klose P, Fitzcharles MA, et al. Cannabinoids for fibromyalgia. Cochrane Database Syst Rev. 2016 Jul 18;(7):CD011694.Full text Abstract
185. Fitzcharles MA, Niaki OZ, Hauser W, et al. Position statement: a pragmatic approach for medical cannabis and patients with rheumatic diseases. J Rheumatol. 2019 May;46(5):532-8.Full text Abstract
186. Berger AA, Keefe J, Winnick A, et al. Cannabis and cannabidiol (CBD) for the treatment of fibromyalgia. Best Pract Res Clin Anaesthesiol. 2020 Sep;34(3):617-31. Abstract
187. Guillouard M, Authier N, Pereira B, et al. Cannabis use assessment and its impact on pain in rheumatologic diseases: a systematic review and meta-analysis. Rheumatology (Oxford). 2021 Feb;60(2):549-56.Full text Abstract
188. Cohen SP, Verdolin MH, Chang AS, et al. The intravenous ketamine test predicts subsequent response to an oral dextromethorphan treatment regimen in fibromyalgia patients. J Pain. 2006 Jun;7(6):391-8. Abstract
189. Kurian R, Raza K, Shanthanna H. A systematic review and meta-analysis of memantine for the prevention or treatment of chronic pain. Eur J Pain. 2019 Aug;23(7):1234-50.Full text Abstract
190. Arnold LM, Chatamra K, Hirsch I, et al. Safety and efficacy of esreboxetine in patients with fibromyalgia: an 8-week, multicenter, randomized, double-blind, placebo-controlled study. Clin Ther. 2010 Aug;32(9):1618-32. Abstract
191. Welsch P, Bernardy K, Derry S, et al. Mirtazapine for fibromyalgia in adults. Cochrane Database Syst Rev. 2018 Aug;8(8):CD012708.Full text Abstract
192. Hemati K, Amini Kadijani A, Sayehmiri F, et al. Melatonin in the treatment of fibromyalgia symptoms: a systematic review. Complement Ther Clin Pract. 2020 Feb;38:101072.Full text Abstract
193. Johnson MI, Claydon LS, Herbison GP, et al. Transcutaneous electrical nerve stimulation (TENS) for fibromyalgia in adults. Cochrane Database Syst Rev. 2017 Oct 9;(10):CD012172.Full text Abstract
194. Dailey DL, Vance CGT, Rakel BA, et al. Transcutaneous electrical nerve stimulation reduces movement-evoked pain and fatigue: a randomized, controlled trial. Arthritis Rheumatol. 2020 May;72(5):824-36.Full text Abstract
195. Lange G, Janal MN, Maniker A, et al. Safety and efficacy of vagus nerve stimulation in fibromyalgia: a phase I/II proof of concept trial. Pain Med. 2011 Sep;12(9):1406-13.Full text Abstract
196. Cao H, Liu J, Lewith GT. Traditional Chinese Medicine for treatment of fibromyalgia: a systematic review of randomized controlled trials. J Altern Complement Med. 2010 Apr;16(4):397-409. Abstract
197. Sarmiento-Hernández I, Pérez-Marín MLÁ, Nunez-Nagy S, et al. Effectiveness of invasive techniques in patients with fibromyalgia: systematic review and meta-analysis. Pain Med. 2020 Dec;21(12):3499-511.Full text Abstract
198. Deare JC, Zheng Z, Xue CC, et al. Acupuncture for treating fibromyalgia. Cochrane Database Syst Rev. 2013 May;2013(5):CD007070.Full text Abstract
199. Radvanski DC, Vaschillo EG, Vaschillo B, et al. A pilot study of the efficacy of heart rate variability (HRV) biofeedback in patients with fibromyalgia. App Psychophys Biofeedback. 2007 Mar;32(1):1-10. Abstract
200. Babu AS, Mathew E, Danda D, et al. Management of patients with fibromyalgia using biofeedback: a randomized control trial. Indian J Med Sci. 2007 Aug;61(8):455-61. Abstract
201. Porter NS, Jason LA, Boulton A, et al. Alternative medical interventions used in the treatment and management of myalgic encephalomyelitis/chronic fatigue syndrome and fibromyalgia. J Altern Complement Med. 2010 Mar;16(3):235-49. Abstract
202. Ferreira I, Ortigoza Á, Moore P. Magnesium and malic acid supplement for fibromyalgia. [in spa]. Medwave. 2019 May;19(4):e7633. Abstract
203. Mehrabani S, Askari G, Miraghajani M, et al. Effect of coenzyme Q10 supplementation on fatigue: a systematic review of interventional studies. Complement Ther Med. 2019 Apr;43:181-7.Full text Abstract
204. Perry R, Terry R, Ernst E. A systematic review of homoeopathy for the treatment of fibromyalgia. Clin Rheumatol. 2010 May;29(5):457-64. Abstract
205. Langhorst J, Musial F, Klose P, et al. Efficacy of hydrotherapy in fibromyalgia syndrome - a meta-analysis of randomized controlled clinical trials. Rheumatology (Oxford). 2009 Sep;48(9):1155-9. Abstract
206. Antonelli M, Donelli D, Veronesi L, et al. Clinical efficacy of medical hydrology: an umbrella review. Int J Biometeorol. 2021 Oct;65(10):1597-614. Abstract
207. Schneider M, Vernon H, Ko G, et al. Chiropractic management of fibromyalgia syndrome: a systematic review of the literature. J Manipulative Physiol Ther. 2009 Jan;32(1):25-40. Abstract
208. Bronfort GH, Haas M, Evans R, et al. Effectiveness of manual therapies: the UK evidence report. Chiroprac Osteopat. 2010 Feb 25;18:3.Full text Abstract
209. Kalichman L. Massage therapy for fibromyalgia symptoms. Rheumatol Int. 2010 Jul;30(9):1151-7. Abstract
210. Ernst E. Chiropractic treatment for fibromyalgia: a systematic review. Clin Rheumatol. 2009 Oct;28(10):1175-8. Abstract
211. Chen KW, Hassett AL, Hou F, et al. A pilot study of external qigong therapy for patients with fibromyalgia. J Altern Complement Med. 2006 Nov;12(9):851-6. Abstract
212. Brosseau L, Wells GA, Tugwell P, et al. Ottawa Panel evidence-based clinical practice guidelines for aerobic fitness exercises in the management of fibromyalgia: part 1. Phys Ther. 2008 Jul;88(7):857-71.Full text Abstract
213. Brosseau L, Wells GA, Tugwell P, et al. Ottawa Panel evidence-based clinical practice guidelines for strengthening exercises in the management of fibromyalgia: part 2. Phys Ther. 2008 Jul;88(7):873-86.Full text Abstract
214. D'Onghia M, Ciaffi J, McVeigh JG, et al. Fibromyalgia syndrome - a risk factor for poor outcomes following orthopaedic surgery: a systematic review. Semin Arthritis Rheum. 2021 Aug;51(4):793-803.Full text Abstract
215. Dreyer L, Kendall S, Danneskiold-Samsøe B, et al. Mortality in a cohort of Danish patients with fibromyalgia: increased frequency of suicide. Arthritis Rheum. 2010 Oct;62(10):3101-8.Full text Abstract
216. McKernan LC, Lenert MC, Crofford LJ, et al. Outpatient engagement and predicted risk of suicide attempts in fibromyalgia. Arthritis Care Res (Hoboken). 2019 Sep;71(9):1255-63.Full text Abstract
217. Gill H, Perez CD, Gill B, et al. The prevalence of suicidal behaviour in fibromyalgia patients. Prog Neuropsychopharmacol Biol Psychiatry. 2021 Jun 8;108:110078.Full text Abstract
218. Basavakumar D, Flegg M, Eccles J, et al. Accuracy, completeness and accessibility of online information on fibromyalgia. Rheumatol Int. 2019 Apr;39(4):735-42.Full text Abstract
219. Ozsoy-Unubol T, Alanbay-Yagci E. YouTube as a source of information on fibromyalgia. Int J Rheum Dis. 2021 Feb;24(2):197-202.Full text Abstract
220. Rooks DS. Fibromyalgia treatment update. Curr Opin Rheumatol. 2007 Mar;19(2):111-7. Abstract
Use of this content is subject to our disclaimer